Efficacy and Safety of Rituximab in Refractory CIDP With or Without IgG4 Autoantibodies (RECIPE): Protocol for a Double-Blind, Randomized, Placebo-Controlled Clinical Trial - PubMedTwitterFacebookLinkedInGitHubTwitterSM-FacebookSM-Youtube

DERR1-10.2196/17117.